Tokai Ventures

Tokai Ventures is a Montevideo-based VC focused on Uruguayan founders building scalable software for global markets, writing seed and Series A checks in the $250K to $1M range. The firm’s healthcare interest spans digital health and health IT software, and Tokai is not positioned as an AI-native specialist; the lens is fundamentally commercial and global-software-focused. Uruguay’s outsized software-export footprint relative to its small domestic market means that the most compelling Uruguayan companies are typically global from day one, and Tokai’s positioning reflects that reality. The geographic focus is Uruguayan founders with global commercial markets, and the firm’s network spans the Montevideo technical community and the broader Latin American and US software-investor ecosystem. The right founder profile is a Uruguayan technical founder building B2B software for healthcare or health IT buyers with a global GTM strategy from inception, ideally with engineering depth and a defensible product wedge. The wrong fit is a research-stage biotech, a Latin-America-only digital health business, or a deep-tech AI platform; Tokai’s mandate is concentrated in global software with Uruguayan operating leverage. The right entry path is through Montevideo founder networks, through Universidad de la Republica and ORT alumni communities, through Uruguayan diaspora operators based in the US, and through warm introductions from regional co-investors at firms like Globant Ventures, NXTP, Magma Partners, and Kaszek. When pitching, lead with the technical credibility, the global GTM strategy, the early commercial signal in target markets, and the unit economics that benefit from Uruguayan engineering cost structure with global pricing. Then connect to the path to US institutional capital at Series A and beyond. Caveats: Tokai is a small fund with limited follow-on capacity, and Uruguay’s domestic market alone is too small to support a venture-scale outcome, so a credible global expansion thesis is essential. Founders should plan for the next round of capital from larger US and Latin American firms as the metrics warrant. The healthcare-specific operating expertise is also generalist rather than deep. Use Tokai as the local launchpad that anchors your globally ambitious Uruguayan healthtech company in its technical ecosystem.